Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

LifeVantage Corp (NASDAQ:LFVN)

8.27
Delayed Data
As of Dec 07
 0.00 / 0.00%
Today’s Change
6.43
Today|||52-Week Range
15.97
-13.13%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$109.1M

Company Description

LifeVantage Corp. is a science-based company. It engages in the identification, research, development, manufacture, and distribution of an advanced nutraceutical dietary supplement, including products Protandim; the Nrf2 Synergizer; Axio, anti-aging skin care product; LifeVantage TrueScience; and Canine Health. The firm operates through the Americas; and Asia or Pacific geographical segments. It currently focuses on oxidative stress solutions, particularly the activation of nuclear factor which relates to cardiovascular, central nervous system, inflammatory, and metabolic diseases as well as other health related disorders. The company was founded in June 1988 and is headquartered in Sandy, UT.

Contact Information

LifeVantage Corp.
9785 South Monroe Street
Sandy Utah 84070
P:(866) 460-7241
Investor Relations:
(858) 432-9036

Employees

Shareholders

Other institutional20.41%
Mutual fund holders10.96%
Individual stakeholders1.99%

Top Executives

Darren JensenPresident, Chief Executive Officer & Director
Robert M. UrbanChief Operating Officer
Mark JaggiChief Financial Officer
Nathalie ChevreauSenior Vice President Research & Development
Moy ChambersSenior Vice President-Information Technology